| Date | Title | Description |
| 21.03.2026 | Surf Therapeutics Secures $6M, Advances Non-Invasive Arthritis Treatment | Surf Therapeutics, an Austin, Texas biotechnology firm, has raised $6 million in total seed funding. This capital boost supports its innovative non-invasive ultrasound neuromodulation therapy. The company's SUSTAIN platform targets chronic ... |
| 17.03.2026 | Surf Therapeutics: $6 Million Raised As Ultrasound Neuromodulation Company Advances Rheumatoid Arthritis Clinical Study | Surf Therapeutics, a clinical-stage biotechnology company developing non-invasive ultrasound neuromodulation therapies for immune-mediated diseases, announced positive first-in-human study results alongside an extension of its seed financin... |
| 17.03.2026 | Surf Therapeutics Extends Seed Funding; Raises $6M in Total | Surf Therapeutics, an Austin, TX-based clinical-stage company developing non-invasive ultrasound neuromodulation therapies, raised an undisclosed amount in Seed expansion funding.
The amount of the deal was not disclosed.
This financing bui... |
| 22.07.2024 | Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering | SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announc... |
| 22.07.2024 | Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering | SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announc... |
| 19.06.2022 | Five of the world’s tiniest robots | The RoboFly
Allow me to take you on a trip down my memory lane. As a young lad, a film I saw captured my imagination: Fantastic Voyage, a 1966 release about people shrunk to microscopic size and sent into the body of an injured scientist to... |
| 03.08.2021 | Rani Therapeutics’ $73M IPO will fund upcoming clinical trials | Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday.
According to S-1 filings, shares were estimated to price between $14 and $16 last week. On Friday, shares debuted slightly l... |
| 05.03.2021 | How Rani Therapeutics’ robotic pill could change subcutaneous injection treatment | A new auto-injecting pill might soon become a replacement for subcutaneous injection treatments.
The idea for this so-called robotic pill came out of a research project around eight years ago from InCube Labs — a life sciences lab operated ... |
| 11.12.2020 | Weekly Wrap #32: Pizza Arbitrage, Bed Photographers and Maggots | Welcome to our Weekly Wrap, where we cut through the noise to bring you our favourite insights from the technology and startup world.
Please keep the great feedback coming. If you love the Weekly Wrap, share away.
Share
Seen any interesting... |
| 10.12.2020 | Rani Therapeutics nets $69M to transform injections into its easy-to-swallow 'robotic pill' | Rani Therapeutics has secured $69 million in new funding to move forward with the manufacturing and clinical testing of its “robotic pill”—a small, swallowable capsule that promises to shepherd more delicate drugs past the stomach before re... |
| 10.12.2020 | Rani Therapeutics Pulls In $69M Series E |
SAN JOSE, CA, Rani Therapeutics today announced that it has raised $69 million in a Series E financing round.
>> Click here for more funding data on Rani Therapeutics
>> To export Rani Therapeutics funding data to PDF and Ex... |
| 10.12.2020 | Rani raises $69 million to convert injectable drugs into pill form | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Rani Therapeutics today announced a $69 million r... |
| 10.12.2020 | Rani raises $69 million to convert injectable drugs into pill form | Rani Therapeutics today announced a $69 million round to fund development of its platform that converts injectable drugs into pills. The San Jose-based company specifically plans to accelerate clinical development of its internal pipeline t... |
| 10.12.2020 | Rani Therapeutics nets $69M to transform injections into its easy-to-swallow 'robotic pill' | Rani Therapeutics has secured $69 million in new funding to move forward with the manufacturing and clinical testing of its “robotic pill”—a small, swallowable capsule that promises to shepherd more delicate drugs past the stomach before re... |
| 08.02.2018 | Term Sheet — Thursday, February 8 | ARMED WITH DATA
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Ohanian said he will return to Initialized Capital, an early-stage VC firm he co-founded with Garry Tan, as a full-time general... |
| 08.02.2018 | GV-backed startup Rani gets $53M from new investors for 'robotic pill' | A Google-backed startup that’s developing a new way to turn injectable drugs like insulin into pills, has raised an additional $53 million from a slew of new investors to prep for clinical trials.
Mir Imran
The company, ca... |
| 08.02.2018 | Rani Therapeutics Raises $53M in Funding | Rani Therapeutics, the San Jose, CA-based developer of a pill designed to replace injectable drug delivery for patients suffering from chronic diseases, raised $53m in funding.
This round, which brought the total raised to $142m in funding,... |
| 13.09.2017 | Rani Therapeutics Raises $39M in Series D |
SAN JOSE, CA, Rani Therapeutics has raised $39 million in Series D funding.
>> Click here for more funding data on Rani Therapeutics
>> To export Rani Therapeutics funding data to PDF and Excel, click here
According to pu... |
| 13.09.2017 | Rani Therapeutics Raises $39M in Series D Funding | Rani Therapeutics, a San Jose, CA-based developer of technology to convert injectable drugs into oral pills, raised $39M in Series D funding.
GV (Google Ventures) is among the investors participating in this round, which brings total fundin... |
| 13.09.2017 | Term Sheet — Wednesday, September 13 | CRYPTO DRAMA
JAMIE DIMON VS. THE INTERNET: J.P. Morgan CEO Jamie Dimon lit the Internet on fire yesterday after his remarks about how Bitcoin is “a fraud” and how he would fire any employee trading bitcoin for being “stupid.”
Paid Content W... |
| 24.02.2016 | AstraZeneca invests in oral biologics startup Rani Therapeutics | The company is developing a means to convert injectable drugs – such as basal insulin, TNF-alpha inhibitors and interleukin antibodies – into oral biologics. It’s been working with Novartis and AstraZeneca/MedImmune for the past year or so.... |
| 24.02.2016 | Daily funding roundup - February 24, 2016 | Polypid closed $22M; NoBaker raised $10M funding; ClearMetal closed $3M Seed funding
Paysa, provider of market salary data, raised $4 million in seed funding from New Enterprise Associates (NEA), Milliway Ventures, and other private investo... |
| 24.02.2016 | Rani Therapeutics Closes Funding | Rani Therapeutics, a San Jose, CA-based developer of a novel approach for the oral delivery of peptides, proteins and therapeutic antibodies, closed its latest round of funding.
Backers in the round, which brought the total funding raised t... |
| 27.05.2015 | Rani Therapeutics Closes Series C Round of Funding | Rani Therapeutics, a San Jose CA-based developer of a novel approach for the oral delivery of large drug molecules, closed a Series C round of funding of undisclosed amount.
Participants included Novartis, Google Ventures, InCube Ventures, ... |
| 28.08.2013 | Rani Therapeutics Closes Series B Funding | Rani Therapeutics, a San Jose CA-based developer of a platform to convert injectable drugs into pills, closed its Series B funding of undisclosed amount.
The round was led by Google Ventures, with participation from InCube Ventures and Vent... |
| 28.08.2013 | Rani Therapeutics Secures Series B |
SAN JOSE, CA, Rani Therapeutics today announced it has closed its Series B round of funding, led by Google Ventures.
>> Click here for more funding data on Rani Therapeutics
>> To export Rani Therapeutics funding data to PDF... |
| - | AstraZeneca invests in oral biologics startup Rani Therapeutics | Bay Area-based startup Rani Therapeutics – which is creating a way to deliver biologic drugs orally – just welcomed another high profile strategic investor: AstraZeneca. This brings the company’s total funding up to $70 million, Rani said i... |
